Related Experiment Video
Updated: Mar 11, 2026

12:30
Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
10.2K
Graphene materials as 2D non-viral gene transfer vector platforms
M Vincent1, I de Lázaro1, K Kostarelos1
1Nanomedicine Laboratory, Faculty of Medical and Human Sciences and National Graphene Institute, University of Manchester, Manchester, UK.
Gene Therapy
|November 23, 2016
Summary
Graphene-based materials show promise as novel non-viral gene delivery vectors. Their unique properties offer potential solutions for efficient and safe genetic cargo transport, advancing gene therapy applications.
Area of Science:
- Biotechnology
- Materials Science
- Genomics
Background:
- Gene therapy holds promise for incurable diseases, but efficient and safe delivery vectors remain a challenge.
- Viral vectors face safety and production issues, while non-viral methods lack sufficient efficiency.
- Graphene-based materials (GBMs) possess unique properties suitable for nucleic acid carrier systems.
Purpose of the Study:
- To explore the potential of graphene-based materials (GBMs) as gene delivery vectors.
- To analyze functionalization strategies for enhancing GBM vector performance.
- To review the biological effects of GBMs in gene transfer applications.
Main Methods:
- Review of existing studies on GBMs for gene transfer.
- Analysis of physicochemical, optical, and photothermal properties of GBMs.
- Examination of functionalization techniques for GBMs.
Main Results:
- GBMs exhibit extraordinary physicochemical, optical, and photothermal properties beneficial for gene delivery.
- Functionalization strategies are crucial for optimizing GBM vector efficiency and safety.
- Early studies indicate potential for GBMs in gene transfer, with ongoing research into biological effects.
Conclusions:
- Graphene-based materials offer a promising platform for developing next-generation gene delivery vectors.
- Further research into functionalization and biological interactions is needed to fully realize GBM potential in gene therapy.
- GBMs could overcome limitations of current viral and non-viral gene delivery systems.
More Related Videos
Related Concept Videos
Gene Therapy
27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

